The University of Texas Southwestern Medical Center has approximately 5,800 active research projects, funded by over $489 million per year from a number of sources; including federal agencies, non-profits, companies, public and private donors.
- 2018 Total R&D Expenditures: $474,260,000
- 2018 Life Science R&D Expenditures: $474,260,000
- Ranked 33rd in Life Science Expenditures
- 2020 Total NIH funding: $21,912,502
- UT Southwestern is currently building (2) nine-story 300k sqft towers on the North Camps. One of those towers will be composed of labs and support space for programs at the Peter O'Donnell Jr. Brain Institute. These towers are part of a $500 million construction project that will also include a new vivarium with research infrastructure on the South Campus. The project is expected to be completed in 2022.
- UT Southwestern received $10 million in 2019 from the National Cancer Institute, to develop more effective, less toxic therapies for Ewing Sarcoma.
- The Center of Excellence for Translational Research at UT Southwestern received over $7 million in 2020 from the National Institute of Allergy and Infectious Diseases (NIAID), to develop host-directed broad-spectrum anti-infective agents to treat infectious diseases, including emerging pathogens. The project has received over $14.5 million in NIAID funding since 2019.